The Chicago Entrepreneur

Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential

The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant advances its stellar drug pipeline.

Previous post The Ratings Game: Wall Street is still too optimistic about Coinbase, BofA says, despite exchange cutting 35% of its staff since June
Next post Biden administration will select first 10 drugs for Medicare price negotiations by September